Core Viewpoint - The company is utilizing temporarily idle raised funds for cash management to enhance fund efficiency and achieve capital preservation and appreciation while ensuring that it does not affect the construction of investment projects or normal operations [2][11]. Cash Management Overview - The purpose of cash management is to reasonably utilize temporarily idle raised funds to improve efficiency and increase returns while ensuring the safety of the raised funds [2]. - The total amount for cash management is 606.98 million yuan [3]. - The source of funds for this cash management is temporarily idle raised funds from a previous stock issuance, which raised a net amount of approximately 791.03 million yuan after deducting issuance costs [4]. Approval Process - The board of directors approved the use of up to 608 million yuan of temporarily idle raised funds for cash management during a meeting held on August 29, 2025 [5]. Specific Cash Management Details - The company is purchasing high-safety, high-liquidity, low-risk deposit products, including but not limited to structured deposits, agreement deposits, notice deposits, time deposits, and large-denomination certificates of deposit [5][7]. - The purchased large-denomination certificates of deposit can be transferred during their term, and the holding period will not exceed 12 months [7]. Investment Risk Analysis and Control Measures - The overall risk of the investment is controllable, but it may be affected by macroeconomic factors and market fluctuations [8]. - The company will adhere to prudent investment principles, select high-safety and low-risk products, and monitor fund operations closely to mitigate risks [9]. Impact on the Company - The cash management of idle raised funds is expected to improve fund efficiency and generate certain investment returns without adversely affecting the company's main business, financial status, or operating results [11]. Current Status of Cash Management - As of the announcement date, the remaining balance of idle raised funds used for cash management is 606.98 million yuan, which is within the authorized limits [12].

Overview of Cash Management - The purpose of cash management is to utilize temporarily idle raised funds to improve efficiency and increase returns while ensuring the safety of the funds and not affecting the company's normal operations [2][3] - The total amount for cash management is 606.98 million yuan [2] - The source of funds for this cash management is temporarily idle raised funds [2] Details of Cash Management - The company has invested in various large-denomination certificates of deposit (CDs) with the following amounts: - 212.75 million yuan for a 3-year CD maturing in 2026 [1] - 94.96 million yuan for a 3-year CD maturing in 2026 [1] - 103.13 million yuan for a 3-year CD maturing in 2027 [1] - 30.79 million yuan for a 3-year CD maturing in 2027 [1] - 165.35 million yuan for a 3-year CD maturing in 2027 [1] - 37.90 million yuan for a 3-year CD maturing in 2027 [1] - The total investment in these CDs amounts to 606.98 million yuan [5] Regulatory Compliance and Approval - The company has received approval from the China Securities Regulatory Commission to issue 164,948,453 shares at a price of 4.85 yuan per share, raising approximately 800 million yuan [3] - The funds raised have been deposited into a special account, and a three-party supervision agreement has been established to ensure proper management [3] Impact on Company Operations - The cash management activities are designed to enhance the efficiency of the raised funds without affecting the ongoing investment projects or the company's normal operations [6] - The company aims to achieve capital preservation and appreciation through this cash management strategy, which is expected to have a minimal impact on its future main business, financial status, and operating results [6]

Core Viewpoint - The company has approved the use of idle raised funds for cash management, allowing up to RMB 250 million for investments in low-risk, liquid financial products with a maturity of no more than 12 months [2][3]. Group 1: Cash Management Approval - The company held its 25th meeting of the 3rd Board of Directors and the 21st meeting of the 3rd Supervisory Board on April 21, 2025, where it approved the proposal to use idle raised funds for cash management [3]. - The approved cash management will not involve investments in stocks, derivatives, or unsecured bonds, focusing instead on safe and liquid products such as structured deposits and large-denomination certificates of deposit [2][3]. Group 2: Financial Performance - During the reporting period, the company utilized a total of RMB 230 million in cash management through large-denomination certificates of deposit and notice deposits, achieving a return of RMB 226,333.33 [3]. - As of June 30, 2025, the remaining balance of idle raised funds used for cash management was RMB 200 million [3].

（文章来源：证券日报） 证券日报网讯 8月20日晚间，南京医药发布公告称，公司于2025年5月19日使用部分暂时闲置募集资金 1.7亿元购买民生银行对公大额存单，该产品已于2025年8月19日到期，公司已赎回本金1.7亿元，并获得 理财收益57.38万元，收益符合预期。本次公司继续使用1.7亿元用于购买民生银行单位大额存单，产品 期限为3个月，年化收益率1.10%。 ...

Core Viewpoint - The company has approved the use of idle raised funds for cash management, with a total limit of up to RMB 50 million, to enhance the efficiency of fund utilization while ensuring that the original purpose of the raised funds remains unchanged [2][9]. Summary by Sections Cash Management Implementation Overview - The purpose of cash management is to improve the efficiency of the use of raised funds without altering their intended use or affecting the normal operation of investment projects [3]. - The amount allocated for cash management is RMB 10 million [3]. - The source of funds for this cash management is the temporarily idle raised funds from the public issuance of convertible bonds in 2022, which totaled RMB 200 million [4][5]. Investment Details - The investment type is large-denomination time deposits, with an investment amount of RMB 10 million [6]. - The company has established a special account for the management of raised funds and signed tripartite supervision agreements with relevant parties to ensure compliance with regulations [7]. Review Procedures - The board of directors and the supervisory board approved the cash management proposal unanimously on July 25, 2024, with no votes against or abstentions [9]. - This decision does not require submission to the shareholders' meeting and does not involve related party transactions [10]. Risk Control Measures - The company will strictly adhere to the board's resolution and ensure that the investment products do not change the intended use of the raised funds [12]. - A thorough pre-review of financial institutions and their products will be conducted to ensure safety and compliance [13]. - The audit department will oversee the use of funds and purchased products, with independent directors and the supervisory board having the right to supervise and inspect fund usage [13]. Impact on Company Operations - As of March 31, 2025, the company's cash management amount represents 1.95% of its cash holdings, 0.52% of its net assets, and 0.28% of its total assets [14]. - The cash management will not affect the construction of projects funded by raised capital or the normal operation of the company's main business, aiming to enhance fund efficiency and provide better returns for shareholders [14]. Supervisory and Sponsor Opinions - The supervisory board agrees that the cash management proposal complies with relevant regulations and does not harm the interests of shareholders, particularly minority shareholders [14]. - The sponsor, Guotai Junan Securities, confirms that the proposal has followed necessary procedures and will not affect the normal operation of the company or its projects [14][15].

Core Viewpoint - The company, Hangzhou Fulai Ant Technology Co., Ltd., has announced the use of part of its idle raised funds for cash management, with a maximum amount of RMB 86 million allocated for low-risk investment products to enhance fund utilization efficiency and generate financial returns for the company and its shareholders [2][13]. Summary by Sections Cash Management Overview - The purpose of cash management is to improve fund utilization efficiency and generate financial returns for the company and its shareholders [3]. - The investment amount for this cash management initiative is RMB 55 million [4]. - The funds used for purchasing financial products are sourced from the company's idle raised funds [4]. Fundraising Background - The company has issued a total of 33.34 million shares at a price of RMB 32.21 per share, raising a total of RMB 1,073.88 million, with a net amount of RMB 974.05 million after deducting issuance costs [5]. Investment Method - The investment type includes large-denomination time deposits, with an investment amount of RMB 55 million [6]. Approval Process - The company held board and supervisory meetings on April 25, 2025, and a shareholder meeting on May 21, 2025, to approve the cash management proposal, allowing the use of idle raised funds for low-risk investment products [8]. Risk Analysis and Control Measures - The company acknowledges that while the investment products are of high safety and liquidity, they are still subject to market fluctuations [9]. - Risk control measures include strict adherence to prudent investment principles, careful selection of issuers, and ongoing monitoring of investment performance [10]. Previous Cash Management - The company has successfully redeemed previous cash management products, indicating a track record of managing idle funds effectively [12]. Impact on the Company - The cash management initiative will not affect the normal operation of the company's fundraising projects or its main business activities [13]. Sponsor's Opinion - The sponsor has expressed no objections to the cash management initiative, confirming that it complies with relevant laws and regulations and will not alter the intended use of raised funds [13].

证券代码：605566 证券简称：福莱蒽特 公告编号：2025-054 杭州福莱蒽特股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回 并继续现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为提高资金使用效率，获取财务收益，为公司及股东获取更多的回报。 （二）现金管理金额 本次投资金额为人民币 5,500 万元。 （三）资金来源 根据中国证券监督管理委员会《关于核准杭州福莱蒽特股份有限公司首次公 开发行股票的批复》（证监许可[2021]3063 号），杭州福莱蒽特股份有限公司实 际已发行人民币普通股 3,334 万股，每股发行价格 32.21 元，募集资金总额为人 民币 1,073,881,400.00 元，减除发行费用人民币 99,830,686.78 元后，募集资金净 额为人民币 974,050,713.22 元。天健会计师事务所（特殊普通合伙）于 2021 年 了专户存储制度，设立了相关募集资金专项账户。募集资金到账后，已全部存放 于经公司董事会批准开设的募集资金专项账户内。 （四）投资方式 | ...

Core Viewpoint - Zhejiang Huatong Meat Products Co., Ltd. has approved the use of idle fundraising funds for cash management, allowing up to RMB 400 million to be invested in high-security, liquid financial products for a period not exceeding 12 months [1][2]. Group 1: Cash Management Details - The company has decided to use part of the idle fundraising funds for cash management, with a maximum amount of RMB 400 million [1][2]. - The cash management products will be purchased within the approved limits and will not affect the company's normal operations [3][4]. - The investment products will have a maximum duration of 12 months and can be rolled over within the approved limits [2][3]. Group 2: Approval Process - The decision was made during the 21st meeting of the 5th Board of Directors and the 17th meeting of the 5th Supervisory Board on May 30, 2025 [1][2]. - The independent directors and the sponsor institution have expressed their agreement with the decision [2]. Group 3: Impact on the Company - The use of idle funds for cash management is expected to enhance the efficiency of fund utilization and generate additional returns for the company and its shareholders [4]. - The company has not engaged in cash management with idle funds in the past twelve months, except for the current instance [4].

Core Viewpoint - The company has approved the use of up to RMB 150 million of idle raised funds for cash management, ensuring that it does not affect the progress of investment projects and effectively controls risks [1][2]. Group 1: Cash Management Approval - The company held its 22nd meeting of the 3rd Board of Directors and the 20th meeting of the 3rd Supervisory Board on August 15, 2024, where it approved the cash management proposal [1]. - The cash management period is valid for 12 months from the date of approval, allowing for rolling use within the specified limit [1]. Group 2: Investment Products - The company plans to invest in structured deposits and other financial products, with a total subscription amount not exceeding RMB 150 million [1]. - Specific products include structured deposits from Suzhou Bank and CITIC Bank, with expected annualized returns to be determined [1][2]. Group 3: Impact on Daily Operations - The use of idle funds for cash management is based on principles of standardized operations, risk prevention, and cautious investment, ensuring that it does not affect the company's daily operations or the normal progress of investment projects [2]. - This approach aims to improve fund utilization efficiency and generate investment returns for the company and its shareholders [2]. Group 4: Previous Cash Management Activities - In the past 12 months, the company has utilized idle raised funds for cash management, with a cumulative balance of RMB 100 million, which is within the authorized cash management limit [3].

Core Viewpoint - Nanjing Pharmaceutical Co., Ltd. has approved the use of up to 700 million yuan of temporarily idle raised funds for cash management, focusing on low-risk, high-liquidity principal-protected financial products [1] Group 1: Cash Management Implementation - The company and its subsidiaries have utilized 142 million yuan to purchase a structured deposit product from Ping An Bank, which is 100% principal-protected and linked to exchange rates, with a 14-day cycle [2] - As of March 19, 2025, the company redeemed part of the financial product, recovering 2 million yuan in principal and earning 0.066 million yuan in interest, which has been returned to the dedicated fundraising account [2] - On April 21, 2025, the company redeemed another portion, recovering 3 million yuan in principal and earning 0.69808 million yuan in interest, also returned to the dedicated fundraising account [3] Group 2: Total Redemption and Earnings - By May 20, 2025, the company redeemed a total of 58 million yuan in principal from the financial products, with total earnings amounting to 1.49874 million yuan [3] - The company has a total cash management limit of 700 million yuan, with 584 million yuan already utilized and 116 million yuan remaining [5] - The highest single-day investment amount in the last 12 months was 700 million yuan, representing 10.24% of the audited net assets for the past year [5]